Florina Regele

Florina Regele

Auto-generated profile, based on publicly available information

Florina Regele

Department of Medicine III, Division of Nephrology and Dialysis Medical University of Vienna Vienna Austria

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2024 in Journal of Medical Virology
Verified
Journal Article
Open access
FRFlorina Regele
Florina Regele
FHFrederik Haupenthal
Frederik Haupenthal
KDKonstantin Doberer
Konstantin Doberer
IGIrene Görzer
Irene Görzer
SKSebastian Kapps
Sebastian Kapps
GBGregor Bond
Gregor Bond
Torque Teno virus (TTV) is nonpathogenic, highly prevalent, and reflects the immune status of its host. Thus, TTV plasma load was suggested for the guidance of immunosuppression post solid organ transplantation. The present study was designed to determine the kinetics of TTV following changes in calcineurin inhibitor (CNI) dose. A total of 48 adult recipients of a kidney graft transplanted at the Medical University of Vienna between 2018 and 2019 with isolated changes in CNI dose were selected from the prospective TTV‐POET trial. TTV plasma load was quantified by in‐house PCR. At Day 30 following CNI dose adaptation (median 33% of daily dose) no changes in TTV load were noted. However, at Day 60, following CNI dose reduction a lower TTV load of 6.4 log10 c/mL (median; interquartile range [IQR] 4.9–8.1) compared with the baseline of 7.1 log10 c/mL (IQR 5.3–8.9) was noted (p = 0.001); there was also a trend toward a higher TTV load following CNI increase (6.6 log10 c/mL, IQR 4.1–9.7 vs. 5.2 log10 c/mL, IQR 4.5–6.8; p = 0.09). The data suggested that TTV load changes become noticeable only 2 months after CNI dose adaptation, which might be the ideal time point for TTV load monitoring.

10 October 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
AHAndreas Heinzel
Andreas Heinzel
ESEva Vanessa Schrezenmeier
Eva Vanessa Schrezenmeier
FRFlorina Regele
Florina Regele
KHKarin Hu
Karin Hu
LRLukas Raab
Lukas Raab
RORainer Oberbauer
Rainer Oberbauer
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial